Clinical Trials Directory

Trials / Completed

CompletedNCT00699556

Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
22 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

This study examines the effect of combined nicotine replacement therapy (transdermal patch + nasal spray vs. transdermal patch + placebo nasal spray) on reactivity to alcohol and self-administration behavior.

Conditions

Interventions

TypeNameDescription
DRUG21mg transdermal nicotine patch (Nicoderm CQ)21mg transdermal nicotine patch
DRUG1mg nicotine nasal spraytwo 0.5mg/sprays, one to each nostril (dose = 1mg) The nicotine nasal spray is formulated by the Investigational Drug Service at Yale-New Haven Hospital. It is similar in concentration to Nicotrol.
DRUGplacebo nasal spraysaline combined with capsaicin to mimic the brief nasal irritation from active nicotine spray The placebo nasal spray is formulated by the Investigational Drug Service at Yale-New Haven Hospital.

Timeline

Start date
2006-01-01
Primary completion
2016-11-01
Completion
2016-11-01
First posted
2008-06-18
Last updated
2018-03-12
Results posted
2018-03-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00699556. Inclusion in this directory is not an endorsement.